Our integrated approach is designed to outsmart cancer’s ability to evolve and resist treatment. Moving beyond reactive, one-size-fits-all strategies to a dynamic, personalized care model that adapts in real time to each patient’s disease biology. By focusing on early, treatment-induced changes and leveraging real-time molecular data, we can deliver the right therapy to the right patient at the right time—fundamentally transforming cancer care for the better.